Skip to content
TrialScanner

NCT05668013

A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Phase 2Active, not recruitingSNYCollaborator

Registry record

Lead sponsor
Teva Branded Pharmaceutical Products R&D LLC
Conditions
Crohn Disease; Colitis, Ulcerative
Primary completion
Jan 5, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05668013 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05668013: A Study to Evaluate the... | TrialScanner